Juliet Tammenoms Bakker, 10% Owner at Aimmune Therapeutics, Inc. (AIMT), bought 78,504 shares at $13.50 ($1.1M) on 2016-03-29, disclosed to the SEC on 2016-03-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.50 | 33,064 | $446K | 41.0% |
| 2 | $14.15 | 45,440 | $643K | 59.0% |
| Total | $13.88 avg | 78,504 | $1.1M | 100% |
| Filing → |
| RXST | BUY | 2024-02-15 | $407K | — | Filing → |
| RXST | SELL | 2023-11-30 | $29.4M | — | Filing → |
| RXST | SELL | 2023-11-16 | $13.6M | — | Filing → |